This site uses cookies to improve user experience by collecting data. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our
Privacy Policy
.
CONFIRM
Acepodia | POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
MENU
CLOSE
ABOUT
About Acepodia
Management Team
Board of Directors
Advisors
TECHNOLOGY
Overview
oNK Cells
ACC
γδ T Cells
PIPELINE
ACC
NEWSROOM
All News
Press Releases
Events & Presentations
Publications
Media
PARTNERSHIPS
CONTACT
Contact Us
Careers
Powerful, accessible cell therapies for patients with cancer.
We develop innovative, highly effective cell therapies for cancer that are broadly accessible for patients.
FIND US
Acepodia USA
1600 Harbor Bay Parkway, Suite 140,
Alameda, CA 94502,
USA
Acepodia Taiwan
Rm. 7, 17F., No.99, Sec. 1, Sintai 5th Rd.,
Sijhih Dist., New Taipei City 22175,
Taiwan (R.O.C.)
CONTACT US
Tel
:
+1 (415) 366 7822
Email
:
info@acepodiabio.com
FOLLOW US
Copyright © 2020 Acepodia Inc.
Privacy Policy
Terms of use
PIPELINE
The Next Generation of Cell Therapies
ACC
ACC
Program
Discovery
Preclinical
Phase I
Phase II
ACE1702
HER2 Targeting, ACC-oNK Cell Therapy
DETAILS
Phase I
HER2-Expressing Solid Tumors (ATHENA)
Phase I
Recruiting Patients
ACE1831
CD20 Targeting, ACC-γδ T Cell Therapy
DETAILS
Preclinical
ACE2016
EGFR Targeting, ACC-γδ T Cell Therapy
DETAILS
Preclinical
ACE1708
PD-L1 Targeting, ACC-γδ T Cell Therapy
DETAILS
Discovery
ACE1975
Target undisclosed, ACC-γδ T Cell Therapy
DETAILS
Discovery
ACE2023
Target undisclosed, ACC-γδ T Cell Therapy
DETAILS
Discovery
We have collaborated with biopharmaceutical partners and academic institutes worldwide.
CONTACT US